Clinical trial
Open Labeled Placebo for Treatment of Cancer Related Fatigue in Patients With Advanced Cancer
NCT03927885 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open Labeled Placebo for Treatment of Cancer Related Fatigue in Patients With Advanced Cancer
- Lead sponsor
- M.D. Anderson Cancer Center
- Phase
- Phase 2/3
- Overall status
- Active, not recruiting
- Start date
- March 30, 2019
- Completion date
- December 31, 2026
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
advanced malignant solid neoplasm, metastatic malignant solid neoplasm, recurrent malignant solid neoplasm